Clinical Trial Update: A Study to Assess Ebola Vaccines ChAd3-EBO-Z and Ad26.ZEBOV [Phase 1]

View source ↗

Summary

Phase 1 trial results for two Ebola vaccine candidates, ChAd3-EBO-Z and Ad26.ZEBOV, have been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ebola Virus Disease

Drugs mentioned

• Ad26.ZEBOV
• ChAd3-EBO-Z

Snippet

Sponsor: University of Oxford | Conditions: Ebola Virus Disease | Phase 1 | Status: COMPLETED